Your session is about to expire
← Back to Search
Diagnostic Test
Aegis CDM Test for Chronic Disease
N/A
Waitlist Available
Research Sponsored by Qure Healthcare, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up [19 months]
Awards & highlights
Study Summary
This trial looks at how primary care docs diagnose & treat common medical conditions, to improve patient care.
Who is the study for?
This trial is for board-certified primary care physicians in the U.S., specifically in Family Medicine or Internal Medicine, with a practice size of at least 40 patients per week. They should treat common conditions like heart disease and diabetes, have internet access, and their patients must have signed HIPAA authorizations.Check my eligibility
What is being tested?
The study is evaluating the Aegis CDM Test along with educational materials to see how they impact doctors' clinical decisions regarding chronic diseases such as metabolic syndrome and cardiometabolic issues.See study design
What are the potential side effects?
Since this trial involves an assessment tool (Aegis CDM Test) and educational materials rather than a medical treatment, there are no direct side effects for patients. The focus is on physician decision-making.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ [19 months]
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~[19 months]
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Chart abstraction measured variation in clinical decisions
Chart abstraction measured variation in quality of care
Chart abstraction measured variation in quantity of care
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Educational Materials and Test AccessExperimental Treatment1 Intervention
These participants will complete their online simulations and treat their real-life patients with access to educational materials and the Aegis test results. Investigators will compare intervention participants' clinical recommendations to those in the control arm.
Group II: Control GroupActive Control1 Intervention
These participants will complete their online simulations and treat their real-life patients without access to the Aegis test.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Aegis CDM Test and Educational Materials
2022
N/A
~120
Find a Location
Who is running the clinical trial?
Qure Healthcare, LLCLead Sponsor
21 Previous Clinical Trials
3,841 Total Patients Enrolled
1 Trials studying Cardiometabolic Syndrome
249 Patients Enrolled for Cardiometabolic Syndrome
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Participants from non-academic medical settings.You have certain common health conditions like irregular heartbeat, heart disease, diabetes, high blood pressure, and high cholesterol.
Research Study Groups:
This trial has the following groups:- Group 1: Educational Materials and Test Access
- Group 2: Control Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there opportunities for candidates to join this clinical trial presently?
"As found on clinicaltrials.gov, this medical research is no longer enrolling participants; the trial began being advertised on July 19th 2022 and was last updated June 15th 2023. Fortunately, there are still 269 other trials actively recruiting patients right now."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger